Valproate reduces retinal ganglion cell apoptosis in rats after optic nerve crush

The retinal ganglion cells of the optic nerve have a limited capacity for self-repair after injury. Valproate is a histone deacetylase inhibitor and multitarget drug, which has been demonstrated to protect retinal neurons. In this study, we established rat models of optic nerve-crush injury and injected valproate into the vitreous cavity immediately after modeling. We evaluated changes in the ultrastructure morphology of the endoplasmic reticulum of retinal ganglion cells over time via transmission electron microscope. Immunohistochemistry and western blot assay revealed that valproate upregulated the expression of the endoplasmic reticulum stress marker glucose-regulated protein 78 and downregulated the expression of transcription factor C/EBP homologous protein, phosphorylated eukaryotic translation initiation factor 2α, and caspase-12 in the endoplasmic reticulum of retinal ganglion cells. These findings suggest that valproate reduces apoptosis of retinal ganglion cells in the rat after optic nerve-crush injury by attenuating phosphorylated eukaryotic translation initiation factor 2α-C/EBP homologous protein signaling and caspase-12 activation during endoplasmic reticulum stress. These findings represent a newly discovered mechanism that regulates how valproate protects neurons.

[1]  Y. Zhuo,et al.  Synaptic or Non-synaptic? Different Intercellular Interactions with Retinal Ganglion Cells in Optic Nerve Regeneration , 2022, Molecular Neurobiology.

[2]  Xiaoli Li,et al.  Neuroprotective effect of minocycline on rat retinal ischemia-reperfusion injury , 2021, Molecular vision.

[3]  Z. Ju,et al.  C/EBP homologous protein deficiency enhances hematopoietic stem cell function via reducing ATF3/ROS‐induced cell apoptosis , 2021, Aging cell.

[4]  Pingpin Chen,et al.  Protective role of PERK-eIF2α-ATF4 pathway in chronic renal failure induced injury of rat hippocampal neurons , 2021, The International journal of neuroscience.

[5]  H. Kim,et al.  Expression of the Endoplasmic Reticulum Stress Marker GRP78 in the Normal Retina and Retinal Degeneration Induced by Blue LED Stimuli in Mice , 2021, Cells.

[6]  S. Safi,et al.  A Systematic Literature Review on Traumatic Optic Neuropathy , 2021, Journal of ophthalmology.

[7]  J. Szaflik,et al.  Neuroprotective Factors of the Retina and Their Role in Promoting Survival of Retinal Ganglion Cells: A Review , 2021, Ophthalmic Research.

[8]  R. Iyengar,et al.  Extracellular histones, a new class of inhibitory molecules of CNS axonal regeneration , 2021, Brain communications.

[9]  E. Duplan,et al.  The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson’s Disease Physiopathology , 2020, Cells.

[10]  L. Benowitz,et al.  Axon Regeneration in the Mammalian Optic Nerve. , 2020, Annual review of vision science.

[11]  J. C. Borges,et al.  Interaction of HSPA5 (Grp78, BIP) with negatively charged phospholipid membranes via oligomerization involving the N-terminal end domain , 2020, Cell Stress and Chaperones.

[12]  B. de Campos Vidal,et al.  Sodium valproate (VPA) interactions with DNA and histones. , 2020, International journal of biological macromolecules.

[13]  Aaron M Williams,et al.  Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury , 2020, Journal of the American Heart Association.

[14]  K. Gokoffski,et al.  Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions. , 2019, Current opinion in neurology.

[15]  M. Shariati,et al.  Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon , 2019, Investigative ophthalmology & visual science.

[16]  Ibrahim M. Ibrahim,et al.  GRP78: A cell's response to stress , 2019, Life Sciences.

[17]  K. Park,et al.  C/EBP homologous protein deficiency inhibits statin‐induced myotoxicity , 2019, Biochemical and biophysical research communications.

[18]  C. Ding,et al.  The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection , 2019, Front. Immunol..

[19]  P. Calabresi,et al.  Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences , 2019, Current neuropharmacology.

[20]  T. Zalewska,et al.  Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders? , 2018, Journal of neuropathology and experimental neurology.

[21]  R. Sihota,et al.  Therapeutic potential of valproic acid in advanced glaucoma: A pilot study , 2018, Indian journal of ophthalmology.

[22]  Travis B. Smith,et al.  Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial , 2018, JAMA ophthalmology.

[23]  Xiangrong Chen,et al.  Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3 , 2018, Journal of neuroinflammation.

[24]  D. L. Lucetti,et al.  Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions , 2018, Pharmacology Biochemistry and Behavior.

[25]  C. Hetz,et al.  The Unfolded Protein Response and Cell Fate Control. , 2017, Molecular cell.

[26]  Juan Yang,et al.  Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  D. Cestari,et al.  Advances in experimental optic nerve regeneration , 2017, Current opinion in ophthalmology.

[28]  R. Libby,et al.  Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury , 2017, Molecular Neurodegeneration.

[29]  Hong-jiang Li,et al.  Exploring Optic Nerve Axon Regeneration , 2017, Current neuropharmacology.

[30]  W. Ridder,et al.  Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss , 2017, Cell Death and Disease.

[31]  Bireswar Laha,et al.  Regenerating optic pathways from the eye to the brain , 2017, Science.

[32]  Sm,et al.  Global Prevalence of , 2017 .

[33]  Caty Casas.  GRP78 at the Centre of the Stage in Cancer and Neuroprotection , 2017, Front. Neurosci..

[34]  Yang Hu.  Axon injury induced endoplasmic reticulum stress and neurodegeneration , 2016, Neural regeneration research.

[35]  T. Harada,et al.  Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration , 2016, International journal of molecular sciences.

[36]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[37]  K. Park,et al.  C/EBP homologous protein (CHOP) gene deficiency attenuates renal ischemia/reperfusion injury in mice. , 2015, Biochimica et biophysica acta.

[38]  L. Tang,et al.  β-III-Tubulin: a reliable marker for retinal ganglion cell labeling in experimental models of glaucoma. , 2015, International journal of ophthalmology.

[39]  Z. Ronai,et al.  UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. , 2015, Trends in biochemical sciences.

[40]  T. Harada,et al.  Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling. , 2015, The American journal of pathology.

[41]  T. Harada,et al.  Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma , 2015, Neuroscience Letters.

[42]  Tianci Chu,et al.  Valproic acid-mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential. , 2015, Regenerative medicine.

[43]  Yiming Li,et al.  New insights into the roles of CHOP-induced apoptosis in ER stress. , 2015, Acta biochimica et biophysica Sinica.

[44]  T. Wong,et al.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. , 2014, Ophthalmology.

[45]  C. Chou,et al.  Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension. , 2014, Investigative ophthalmology & visual science.

[46]  D. Menick,et al.  Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration. , 2014, Experimental eye research.

[47]  Haijian Wu,et al.  Valproic Acid: A New Candidate of Therapeutic Application for the Acute Central Nervous System Injuries , 2014, Neurochemical Research.

[48]  L. Massieu,et al.  Glucose deprivation induces reticulum stress by the PERK pathway and caspase-7- and calpain-mediated caspase-12 activation , 2014, Apoptosis.

[49]  O. Gorbatyuk,et al.  The Molecular Chaperone GRP78/BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini Review. , 2013, Journal of genetic syndromes & gene therapy.

[50]  I. Pang,et al.  Challenges in the development of glaucoma neuroprotection therapy , 2013, Cell and Tissue Research.

[51]  W. Zhang,et al.  Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush , 2012, Neuroscience.

[52]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[53]  L. Glimcher,et al.  Differential Effects of Unfolded Protein Response Pathways on Axon Injury-Induced Death of Retinal Ganglion Cells , 2012, Neuron.

[54]  Yuanyuan Gong,et al.  Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation. , 2012, Experimental eye research.

[55]  Wang-Tso Lee,et al.  Role of glucose-regulated Protein 78 in embryonic development and neurological disorders. , 2011, Journal of the Formosan Medical Association = Taiwan yi zhi.

[56]  Caty Casas,et al.  Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury , 2011, Neuroscience.

[57]  W. Lagrèze,et al.  Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells , 2011, Molecular vision.

[58]  F. Urano,et al.  Measuring ER stress and the unfolded protein response using mammalian tissue culture system. , 2011, Methods in enzymology.

[59]  S. Di Giovanni,et al.  Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. , 2010, Investigative ophthalmology & visual science.

[60]  R. Casson,et al.  Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study , 2010, BMC Neuroscience.

[61]  A. Contestabile,et al.  Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. , 2009, Current molecular pharmacology.

[62]  C. Monneret.  Histone deacetylase inhibitors. , 2005, European journal of medicinal chemistry.

[63]  Junying Yuan,et al.  Cross-Talk between Two Cysteine Protease Families , 2000, The Journal of cell biology.